Probiotics Combined With Targeted Therapy Plus Immunotherapy in Bladder-Preserving Setting for Patients With MIBC

Clinical trial NCT07474064 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07474064
Sponsor: chenxu
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Muscle Invasive Bladder Cancer (MIBC)

Start date: 2026-03-26
Primary completion: 2031-03-31
Enrollment: 146

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.